A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis.
Roy M FleischmannRieke AltenMargarita PileckyteKasia LobelloSteven Y HuaCarol CronenbergerDaniel AlvarezAmy E BockK Lea SewellPublished in: Arthritis research & therapy (2018)
ClinicalTrials.gov Identifier: NCT02480153 . First posted on June 24, 2015; EU Clinical Trials Register EudraCT number: 2014-000352-29 . Start date: October 27, 2014.